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ABSTRACT Maturation of a fraction of mRNAs in nem-
atodes involves the acquisition of a common 5' terminal spliced
leader sequence derived from a nonpolyadenylylated spliced
leader RNA by trans splicing. We have developed a cell-free
system prepared from Ascaris lumbricoides embryos that ac-
curately and efficiently synthesized the spliced leader RNA of
A. lumbricoides. Transcription of the spliced leader RNA was
catalyzed by RNA polymerase H, and the majority of the
spliced leader RNAs synthesized in vitro possessed a trimeth-
ylguanosine cap structure identical to that found on in vivo-
synthesized spliced leader RNA.
In nematodes, a fraction of mRNAs contain an identical
22-nucleotide (nt) spliced leader (SL) sequence at their 5'
ends. Several lines ofevidence indicate that the SL is donated
from a small nonpolyadenylylated transcript (SL RNA)
through a transsplicing reaction (for review, see refs. 1 and 2).
SL RNAs have been characterized in some detail in the
free-living nematode Caenorhabditis elegans and in the par-
asitic nematodes Brugia malayi and Ascaris lumbricoides
(3-5). These RNAs are of similar size (approximately 100 nt)
and all contain the 22-nt SL sequence at their 5' ends.
Studies in several laboratories have shown that these SL
RNAs bear striking similarities to the vertebrate U small
nuclear RNAs (snRNAs) known to be essential for cis
splicing. They contain trimethylguanosine (m'227G) cap
structures and functional binding sites for Sm, a group of
related proteins associated with small nuclear ribonucleopro-
teins (5-8). Furthermore, like U snRNAs, nematode SL
RNAs are transcribed by RNA polymerase 11 (5). Extensive
in vivo analysis of U snRNA transcriptional control elements
has revealed that snRNA genes have unique features that
distinguish them from other genes transcribed by RNA
polymerase II (for review, see ref. 9). However, transcrip-
tion of these genes has generally been inaccessible to the
biochemical manipulations made possible with in vitro sys-
tems.
Here, we describe a cell-free extract prepared from A.
lumbricoides embryos that efficiently synthesized the SL
RNA of A. lumbricoides. Direct analysis of SL RNA tran-
scripts synthesized in vitro indicated that they contained
authentic 5' and 3' termini. Furthermore, a substantive
proportion of the SL RNAs synthesized in vitro contained a
trimethylguanosine cap structure. The availability of this
cell-free system will permit a detailed examination of the
sequence elements that direct both initiation and 3' end
formation of nematode SL RNAs. In addition, this system
may provide an opportunity to biochemically characterize
the components that catalyze SL RNA synthesis and cap
trimethylation.
MATERIALS AND METHODS
Preparation of Extracts. Fertilized Ascaris eggs capable of
synchronous division were prepared from uteri of mature
females as described (10). To prepare extracts, fertilized eggs
were allowed to develop to the 32-cell stage by incubation at
30'C. After removal ofegg shells by treatment with hypochlo-
rite, the eggs were concentrated by centrifugation and
washed several times in ice-cold isotonic phosphate-buffered
saline. After two additional washes in 10 mM KCI/1.5 mM
MgCI2/0.5 mM dithiothreitol/10mM Tris-HCI, pH 7.9 (buffer
A), the eggs were resuspended in a minimal amount of buffer
A and homogenized by 20 strokes in a Dounce homogenizer.
The homogenate was made 200 mM KCI by the addition of
0.25 vol of 1 M KCI, mixed gently for 1 min, and centrifuged
at 15,000 rpm for 10 min in an SS 34 rotor (Sorvall). The
resultant supernatant was dialyzed versus 100 vol of 100 mM
KCI/1 mM dithiothreitol/0.2 mM EDTA/20% (vol/vol) glyc-
erol/20 mM Tris-HCI, pH 7.9 for 4 hr. After dialysis, the
extract was centrifuged at 10,000 rpm for 15 min. The
supernatant was divided into 100-,l aliquots and stored at
-900C.
In Vitro Transcription. In vitro transcription reaction mix-
tures (25 ,l) contained 15 jul ofextract, 3.0 mM MgCl2, 60mM
KCI, 2 mM dithiothreitol, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM
GTP, 50 ,uM UTP, 10 ,uCi [a-32P]UTP, 20 mM creatine
phosphate, 12 mM Tris-HCI (pH 7.9), and 500 ng of super-
coiled template. After a 2-hr incubation at 30°C, reaction
mixtures were diluted to 250 Al in 250 mM NaOAc/20 mM
Tris HCI, pH 7.5/1 mM EDTA/0.25% SDS, digested with
proteinase K (100 ,ug/ml) for 30 min at 37°C, and extracted
with phenol/chloroform, 1:1 (vol/vol). Reaction products
were analyzed on 8 M urea/6% polyacrylamide gels. After
electrophoresis, labeled transcripts were visualized by auto-
radiography. Transcription templates were produced by sub-
cloning segments of the Ascaris 5S rRNA/SL RNA gene
repeat (5) into pBS-ml3+ (Stratagene).
To construct a phage T7 transcription template encoding
the A. lumbricoides SL RNA, the T7 promoter sequence (11)
was fused to the coding sequence of the SL RNA such that
transcription by T7 RNA polymerase would initiate synthesis
with the first guanosine residue of the 22-nt sequence. This
was accomplished by using the polymerase chain reaction
technique with two oligodeoxynucleotides, one containing
the T7 promoter and the first 10 nt of the SL sequence, the
other complementary to the 3' end of the A. lumbricoides SL
RNA coding sequence. This construct was inserted into
pBS-m13+ such that transcription by T7 RNA polymerase
yielded a 116-base synthetic transcript containing 109 bases
Abbreviations: nt, nucleotide(s); SL, spliced leader; snRNA, small
nuclear RNA.
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of SL RNA sequence and 7 bases of polylinker sequence
(GGGGAUC).
Preparation of A. lumbricoides SL RNA Labeled in Vivo. A.
lumbricoides embryos, obtained as described above, were
allowed to develop for 10 days at 30'C (L1 stage) at which
point the larval worms were freed from their egg shells by
gentle Dounce homogenization after hypochlorite treatment.
Freed worms were concentrated by centrifugation (1000 x g
for 1 min) and resuspended in phosphate-free Dulbecco's
modified Eagle's medium (GIBCO) containing carrier-free
[32P]orthophosphate (5 mCi/ml; ICN). After a 3-hr incuba-
tion at 30'C, the worms were again collected by centrifuga-
tion and the resulting pellet was lysed by addition of 1%
SDS/250 mM NaOAc/1 mM EDTA/20 mM Tris HCl, pH
7.5. After a 30-min incubation at 650C, the suspension was
diluted 1:2 and proteinase K (200 ,g/ml) was added. After a
2-hr incubation at 30'C, the lysate was extracted several
times with phenol/chloroform and twice with chloroform
alone. The resulting aqueous phase was made 66% (vol/vol)
ethanol and DNA was removed by "spooling." Precipitated
RNA was recovered by centrifugation and resuspended, and
labeled RNAs were hybrid-selected by using a single-
stranded M13 clone containing sequence complementary to
the A. lumbricoides SL RNA. Selected RNA was eluted from
the DNA by heat denaturation and fractionated on a dena-
turing polyacrylamide gel. A single labeled band, correspond-
ing to SL RNA, was recovered from this gel.
RNA Secondary Analysis. For nearest-neighbor analysis, in-
dividual oligonucleotides were recovered from fingerprints and
digested with RNase T2 or nuclease P1, as described (12).
Digestion products were analyzed by one-dimensional thin
layer chromatography on PEI cellulose plates (Brinkman) (13).
For analysis of capped oligonucleotides, transcripts as
detailed in the text were digested to completion with RNase
T2 and digestion products were resolved in two dimensions
on cellulose plates (Kodak), as described (14). Capped oli-
gonucleotides were recovered and further digested with
nuclease P1 and nucleotide pyrophosphatase (Sigma, P7383).
Digestion products were resolved in two dimensions on
cellulose (see above) in the presence of unlabeled marker
nucleotides (see text).
To compare capped oligonucleotides present on SL RNAs
synthesized in vitro or in vivo, transcripts were digested to
completion with either RNase T2 or nuclease P1. Digestion
products were resolved in two dimensions on cellulose
plates, as detailed (15).
RESULTS
Transcription of A. lumbricoides SL RNA in Embryo Ex-
tract. Using nuclear run-on experiments, it has been shown
(5) that the A. lumbricoides SL RNA is actively synthesized
in early embryos. The SL RNA gene was presumably tran-
scribed by RNA polymerase II since SL RNA synthesis was
inhibited by low levels of a-amanitin. To assay SL RNA
synthesis in vitro, we prepared extracts from synchronous
32-cell A. lumbricoides embryos by using a variety of con-
ditions. In transcription reaction mixtures containing whole-
cell extract, we observed the appearance of an -110-base
transcript in response to addition of cloned templates con-
taining the A. lumbricoides SL RNA gene (Fig. 1, lanes 3 and
5). Synthesis of this transcript was dependent upon the
inclusion of the entire SL RNA coding sequence and was
completely inhibited by a-amanitin at 1 ug/ml (Fig. 1, lanes
4 and 6). As expected, the synthesis of 5S rRNA was
insensitive to this level of inhibitor (Fig. 1, lanes 2 and 4). The
size of the in vitro transcript, specificity of template utiliza-
tion, and sensitivity to a-amanitin suggested that the SL RNA
gene of A. lumbricoides was faithfully transcribed by RNA
polymerase II in the embryo extract.














FIG. 1. Transcription of the A. lumbricoides SL RNA in a
cell-free system. Supercoiled plasmid templates, as schematically
depicted, were included in reaction mixtures containing [32PIUTP in
the presence (lanes 2, 4, and 6) or absence (lanes 1, 3, and 5) of
a-amanitin (1 ,ug/ml). The indicated sizes correspond to the mobility
of labeled restriction fragments electrophoresed in parallel lanes.
RNA Fingerprint Analysis of A. lumbricoides SL RNA Syn-
thesized in Vitro. To assess the accuracy of transcription, we
used two-dimensional RNase T1 fingerprint analysis. For
purposes of comparison, the A. lumbricoides SL RNA coding
sequence was fused to a phage T7 promoter and transcribed by
T7 RNA polymerase in the presence of each of the four
a-32P-labeled ribonucleoside triphosphates. Individual RNase
Ti-resistant oligonucleotides were recovered from two-
dimensional fingerprints of these RNAs. Using RNA second-
ary analysis coupled with knowledge of the DNA sequence of
the template, each oligonucleotide was identified by nearest-
neighbor analysis. A fingerprint of the synthetic transcript
labeled with [a-32P]GTP is shown in Fig. 2C. Oligonucleotide
a is pppGp and oligonucleotide b is CACUUGp, which con-
tains a terminal guanosine derived from the vector.
A fingerprint of A. lumbricoides SL RNA synthesized in
embryo extract is shown in Fig. 2F. A comparison of this
fingerprint with that of the T7-synthesized RNA indicated
that the SL RNA synthesized in extract contained a com-
plement of RNase Ti-resistant oligonucleotides that exactly
corresponded to those of the T7 RNA with the following three
exceptions: (i) the SL RNA synthesized in extract contained
a capped oligonucleotide (spot 15), whose sequence was
determined as described below; (ii) it contained neither
pppGp nor other vector-derived sequences; and (iii) extract-
synthesized SL RNA contained a 3' terminal oligonucleotide
CACUOH (spot 20) (see below). A comparison of this finger-
print with the fingerprint of SL RNA synthesized in vivo (Fig.
2G) indicated that these RNAs contained a strikingly similar
pattern of fingerprint spots. In particular, the two RNAs
appeared to share the same 5' capped oligonucleotide and to
terminate at the same 3' position. The minor differences
between these RNAs are discussed below.
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FIG. 2. RNase T1 fingerprint analysis of A. lumbricoides SL
RNA synthesized in vitro and in vivo. (A) Sequence of the A.
lumbricoides SL RNA. Slashes separate oligonucleotides resulting
from digestion of in vitro-synthesized SL RNA with RNase T1.
Identification of the cap structure is described in the text and in Fig.
3. (B) Schematic representation of an RNase T1 fingerprint of A.
lumbricoides SL RNA in which oligonucleotides are numbered with
reference to A. Identification of oligonucleotides is described in the
text. (C) RNase T1 fingerprint of a synthetic SL RNA synthesized
by T7 RNA polymerase. Oligonucleotide a is pppGp and oligonu-
cleotide b is CACUUGp, which contains vector sequence. (D)
Fingerprint of SL RNA synthesized in extract in the presence of
[a-32P]GTP. (E) Fingerprint of SL RNA synthesized in extract in the
presence of [a-32P]UTP. (F) Fingerprint of SL RNA synthesized in
extract in the presence of all four [a-32P]rNTPs. (G) Fingerprint of
SL RNA synthesized in vivo in the presence of [32P]orthophosphate.
SL RNA synthesized in vivo was prepared. Oligonucleotide X is not
present on fingerprints of SL RNAs synthesized in extract and has
not been identified. The dotted circle indicates the position of an
Identification of 3' and 5' Terminal Oligonucleotides of A.
lumbricoides SL RNA Synthesized in Vitro. It seemed likely
that fingerprint spot 20 in Fig. 2 B, E, F, and G was the 3'
terminus of the in vitro-synthesized SL RNA, since this
oligonucleotide was absent from fingerprints of both the
T7-synthesized RNA and [32P]GTP-labeled SL RNA synthe-
sized in extract (Fig. 2 C and D) but was present in extract-
synthesized RNAs labeled with [32P]UTP (Fig. 2E), [32p]_
ATP, or [32P]CTP (data not shown). To confirm the identity
of this spot, it was excised from fingerprints of uniformly
labeled extract-synthesized RNA and subjected to further
analysis. The mobility of this oligonucleotide on a 20%
polyacrylamide gel was unaltered by treatment with phos-
phatase, indicating that it had no terminal phosphate groups.
Digestion with RNase T2 yielded 2 mol ofCp and 1 mol ofAp,
whereas digestion with nuclease P1 yielded 1 mol of pU, 1
mol of pC, and 1 mol of pA. Again, taking into account the
sequence of the template and the fact that all other oligonu-
cleotides were identified, we concluded from these analyses
that the SL RNA synthesized in extract terminated with the
3' oligonucleotide CACUOH 108 nt downstream of the first
base of the SL sequence. Two lines ofevidence indicated that
this represented authentic 3'-end formation in vitro. (i) A
fingerprint spot with identical mobility was observed with in
vivo-labeled SL RNA (Fig. 2G). (ii) Direct sequence analysis
of [32P]pCp-end-labeled SL RNA indicated that authentic SL
RNA terminated in the sequence CACU (data not shown).
Similarly, the 5' terminal oligonucleotide of the in vitro-
synthesized SL RNA (spot 15) was identified by several
criteria. This spot was not present in fingerprints of the T7
transcript (Fig. 2C) or on fingerprints of extract synthesized
SL RNA labeled with [32P]CTP or [32PJATP (data not shown)
but was present on fingerprints of [32P]GTP-labeled or
[32P]UTP-labeled SL RNA synthesized in extract (Fig. 2 D
and E). Furthermore, when SL RNA labeled with [32P]GTP
was digested with RNase T1 and the digestion products were
precipitated with a monoclonal antibody directed against
trimethylguanosine cap structures (16), only this oligonucle-
otide was bound by the antibody (data not shown, and see
below). We concluded from these analyses that spot 15
represented a capped oligonucleotide derived from the 5'
terminus of the SL RNA. This appeared to correspond to the
authentic 5' terminus of A. lumbricoides SL RNA since an
oligonucleotide of identical mobility was present in the fin-
gerprint ofSL RNA labeled in vivo (compare Fig. 2 F and G);
although in the fingerprint of in vivo-labeled SL RNA, the
presumptive capped oligonucleotide had a much greater
relative intensity than the corresponding spot in fingerprints
of SL RNA transcribed in extract. We cannot presently
explain this difference in intensity and have not been able to
recover sufficient amounts of the in vivo-labeled spot for
detailed secondary analysis. However, two additional lines of
evidence suggested that the 5' terminus of SL RNA was
faithfully generated in vitro. Both in vivo- and in vitro-labeled
SL RNAs were prepared and digested to completion with
RNase T2 or nuclease P1 and the digestion products were
resolved by two-dimensional thin layer chromatography (15).
In both cases the capped oligonucleotides of the two RNAs
migrated identically (data not shown).
expected oligonucleotide that was absent from this fingerprint.
Arrows I and II indicate the first dimension (gel electrophoresis) and
second dimension (homochromatography), respectively (12). Ex-
tract-synthesized SL RNAs used for fingerprint analysis were pre-
pared from transcription reactions similar to those shown in Fig. 1,
lane 5. After deproteinization, reaction products were precipitated
with a monoclonal antibody directed against trimethylguanosine (16).
Precipitated RNAs were then fractionated on denaturing polyacryl-
amide gels. After autoradiography, labeled RNAs were recovered
from gels prior to two-dimensional fingerprint analysis.
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Structure of the Cap on in Vitro-Synthesized SL RNA. To
examine in detail the cap structure present on the SL RNA
synthesized in the whole-cell extract, [a-32P]GTP-labeled
transcripts were precipitated with the monoclonal antibody
specific for trimethylguanosine caps (16). This treatment
resulted in the precipitation of approximately 60% of the SL
RNA transcripts, suggesting that this fraction of the SL
RNAs synthesized in vitro contained a trimethylguanosine
cap structure (Fig. 3A, lanes 1 and 2). To confirm this
interpretation and to determine the cap structure present on
the RNA that was not immunoprecipitated, bound and un-
bound RNAs were digested to completion with RNase T2
(Fig. 3B, chromatographs 1 and 2) and digestion products
were resolved in two dimensions (14). Capped oligonucleo-
tides were recovered for further digestion with nuclease P1
and nucleotide pyrophosphatase, and the redigestion prod-
ucts were again resolved by two-dimensional thin layer
chromatography (Fig. 3B, chromatographs 3 and 4). Upon
digestion the capped oligonucleotides of antibody-bound and
unbound RNAs yielded three products each. The three
products generated from unbound RNA exactly comigrated
with pG, pGm, and pm7G. Digestion of capped oligonucle-
otide derived from antibody-bound material yielded pG,
pGm, and pm 2'27G. We concluded from these analyses that
the SL RNAs synthesized in vitro contained a mixture ofcap
structures; the unbound RNA had the cap m7GpppGmGp and
the bound RNA had the cap m2,2'7GpppGmGp. When these
A
1 2
results were combined with the fingerprint analysis described
above we concluded that transcription of the SL RNA gene
in whole-cell extract was initiated at the first guanosine
residue of the 22-nt SL sequence and that a large proportion
of these transcripts were further modified to contain an
authentic trimethylguanosine cap structure. In addition, most
if not all of the SL RNA synthesized in vitro contained a
2'-0-methylated guanosine residue (the first guanine residue
of the 22-nt SL sequence).
DISCUSSION
We have shown here that the SL RNA gene of A. lumbri-
coides is efficiently transcribed by RNA polymerase II in an
A. lumbricoides whole-cell extract prepared from developing
embryos. Several lines of evidence including two-dimen-
sional RNase T1 fingerprint analysis indicate that in vitro
transcription is accurate with respect to initiation and 3' end
formation. Furthermore, greater than 50% of the in vitro SL
RNA transcripts are modified by the addition of trimethyl-
guanosine cap structures.
Although it is clear from the fingerprint and other analyses
that the in vitro SL RNA transcript is quite similar to its in
vivo counterpart, there are some differences. Specifically,
the capped oligonucleotide is disproportionately labeled in
fingerprints ofRNA labeled in vivo and one expected RNase



















FIG. 3. SL RNA synthesized in extract contains a trimethylguanosine cap structure. SL RNA and 5S rRNA were synthesized in extract in
the presence of [a-32P]GTP in reactions similar to those shown in Fig. 1, lane 3. After deproteinization, the mixture of RNAs was precipitated
with a monoclonal antibody specific for trimethylguanosine, and aliquots of unbound and bound fractions were analyzed by denaturing gel
electrophoresis. (A) Unbound (lane 1) and bound (lane 2) RNAs. Sizes correspond to the mobility oflabeled restriction fragments electrophoresed
in parallel lanes. To analyze cap structures, bound and unbound SL RNAs were recovered from gels similar to those in A and digested to
completion with RNase T2. Digestion products of unbound (B, chromatograph 1) or bound (B, chromatograph 2) RNAs were resolved by
two-dimensional thin layer chromatography, as described (14). Capped oligonucleotides from each RNA (spot a, unbound, and spot c, bound)
were recovered and further digested with nuclease P1 and nucleotide pyrophosphatase. Digestion products were again resolved by
two-dimensional TLC (unbound in B, chromatograph 3; bound in B, chromatograph 4). The positions of unlabeled standards that were mixed
with the labeled nucleotides prior to chromatography are indicated. Trimethylguanosine containing cap standards were synthesized (15) and
provided by S. Tahara and E. Darzynkiewicz (Department of Microbiology, University of Southern California, Los Angeles); remaining
standards were purchased from Pharmacia. Spots b and x in B, chromatograph 1, represent residual trimethylguanosine cap remaining after
immunoprecipitation and an unidentified minor cap present in the unbound RNA, respectively.
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of this RNA (see Fig. 2). Furthermore, one unidentified
oligonucleotide is present on this fingerprint (see Fig. 2). It
might be possible to explain the disproportionate cap spot
intensity if the guanosine pool used for cap structures equil-
ibrates more rapidly with the orthophosphate used in label-
ing. The other differences could be accounted for if the SL
RNA synthesized in vivo is subject to additional modifica-
tions, which are not catalyzed in the extract; however,
support for these conjectures awaits a more detailed analysis
of the SL RNA synthesized in vivo.
In addition to the studies presented regarding transcription
of the A. lumbricoides SL RNA gene, we have used indirect
analysis (such as primer extension and oligodeoxynucleotide-
directed RNase H digestion) to show that the SL RNA genes
of both B. malayi and C. elegans are faithfully transcribed in
the A. lumbricoides extract (data not shown). The embryo
extract will thus prove useful to define the transcription
control elements of a variety of nematode SL RNA genes. In
this regard, it has been noted (5, 7) that some potential control
elements for initiation of transcription and 3' end formation
of nematode SL RNAs resemble those known to be important
for the synthesis of vertebrate U snRNAs.
The cell free system should also be useful in determining
the elements that direct cap trimethylation. All three nema-
tode SL RNAs examined have a consensus binding site (RA
Un GR, where n > 3 and R is a purine) for proteins with Sm
antigenic determinants (5-8) and it has been demonstrated
that these sites are functional (6-8). Using enucleated Xe-
nopus oocytes, Mattaj (17) has shown that trimethylation of
U snRNA caps is catalyzed by a cytoplasmic activity and that
the Sm binding site was necessary and sufficient to direct cap
trimethylation. In experiments similar to those described by
others (6-8), we have used human Sm antisera to precipitate
a fraction ofthe A. lumbricoides SL RNA synthesized in vitro
(unpublished observations). It will be of interest to determine
whether SL RNA cap trimethylation requires the binding of
the A. lumbricoides proteins containing Sm antigenic deter-
minants.
Finally, although it is well established that snRNAs are
synthesized by a "modified" form ofRNA polymerase II, the
biochemical analysis of this polymerase and associated fac-
tors has been frustrated by the lack of cell-free transcription
system (for review, see ref. 9). Only three systems, two
derived from sea urchin embryos and one from Xenopus,
have been described which synthesize U snRNAs (18-20).
Thus, in addition to providing information relevant to SL
RNA synthesis, the A. lumbricoides extract may be of more
general significance in providing access to the components of
snRNA synthesis.
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